Table 2.
Group | N[%] cases per ADE code | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A04.7 | D68.33 | D68.34 | D68.35 | D69.52 | D69.53 | I95.2 | K52.1 | L27.0 | L27.1 | N99.0 | Total | 95% CI | ||
G0 - event without drug relationship | 15 [7.1] | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 [1.9] | 17 [1.3] | 0.8–2.1 | |
G1 - known npADE | 195 [92.9] | 42 [91.3] | 7 [100] | 12 [100] | 9 [100] | 41 [100] | 401 [99.0] | 87 [98.9] | 209 [93.7] | 138 [89.6] | 103 [96.2] | 1244 [95.6] | 94.3–96.6 | |
G2 – previously unknown npADE | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 [1.1] | 0 | 2 [1.3] | 0 | 3 [0.2] | 0.1–0.7 | |
G3 - pADE | 0 | 4 [8.7] | 0 | 0 | 0 | 0 | 3 [0.7] | 0 | 14 [6.3] | 14 [9.1] | 2 [1.9] | 37 [2.8] | 2.0–3.9 | |
G4 – event after drug abuse | 0 | 0 | 0 | 0 | 0 | 0 | 1 [0.3] | 0 | 0 | 0 | 0 | 1 [0.1] | 0–0.4 | |
Total | 210 | 46 | 7 | 12 | 9 | 41 | 405 | 88 | 223 | 154 | 107 | 1302 |
npADE non-preventable adverse drug event, pADE preventable adverse drug event, CI confidence interval